Table 1 Differences in cancer-specific quality-of-life domain scores by demographic and clinical characteristics (n = 110)
From: Evaluation of health-related quality of life and its domains in pediatric patients with cancer
Character | Pain & hurt | Nausea | Procedure anxiety | Treatment anxiety | Worry | Cognitive problems | Communication problems | Perceived physical appearance | TSQL |
|---|---|---|---|---|---|---|---|---|---|
MR/P | MR/P | MR/P | MR/P | MR/P | MR/P | MR/P | MR/P | MR/P | |
Age group (years) | |||||||||
< 10 y (n = 42) | 48.6/0.05 | 53.0/0.5 | 51.5/0.09 | 54.7/0.8 | 53.8/0.6 | 49.7/0.1 | 56.5/0.7 | 56.2/0.8 | 50.9/0.2 |
≥ 10 y (n = 68) | 59.7 | 56.9 | 57.9 | 56.0 | 56.5 | 59.0 | 54.8 | 55.0 | 58.3 |
Gender | |||||||||
Male (n = 67) | 53.3/0.3 | 56.6/0.6 | 54.0/0.3 | 53.4/0.4 | 55.2/0.9 | 54.2/0.5 | 51.8/0.1 | 58.5/0.2 | 53.2/0.3 |
Female (n = 43) | 58.8 | 53.7 | 57.7 | 58.6 | 55.9 | 57.5 | 61.2 | 50.8 | 59.0 |
BMI status (percentile) | |||||||||
Underweight (< 5th) | 34.5/0.2 | 31.5/0.5 | 28.5/0.5 | 31.4/0.1 | 26.0/0.6 | 26.1/0.7 | 27.1/0.1 | 26.5/0.3 | 29.5/0.08 |
Normal (5th–85th) | 30.2 | 28.3 | 29.3 | 32.6 | 29.4 | 30.8 | 31.1 | 32.2 | 32.8 |
Overweight (85th–95th) | 30.8 | 36.3 | 28.5 | 26.3 | 29.3 | 26.2 | 36.2 | 29.3 | 29.3 |
Obese (≥ 95th) | 22.1 | 26.7 | 31.7 | 18.6 | 32.1 | 29.2 | 18.7 | 21.1 | 16.5 |
Residence | |||||||||
Urban (n = 43) | 52.6/0.8 | 55.4/0.6 | 54.2/0.7 | 54.5/0.7 | 54.6/0.7 | 57.6/0.2 | 52.2/0.7 | 53.4/0.9 | 53.8/0.9 |
Rural (n = 67) | 54.0 | 52.3 | 53.0 | 52.9 | 52.8 | 51.1 | 54.4 | 53.5 | 53.3 |
Age at diagnosis | |||||||||
< 6 y (n = 27) | 49.5/0.5 | 55.8/0.5 | 51.6/0.8 | 50.8/0.7 | 49.5/0.5 | 58.2/0.3 | 58.6/0.2 | 43.8/0.1 | 53.3/0.8 |
≥ 6 y (n = 83) | 53.2 | 51.6 | 52.7 | 52.9 | 53.2 | 51.0 | 50.9 | 54.7 | 52.2 |
Freq. of visits | |||||||||
< 2 visit/m (n = 69) | 59.8/0.02* | 50.7/0.04 | 55.6/0.6 | 60.6/0.01* | 53.9/0.5 | 55.0/0.9 | 55.9/0.6 | 53.0/0.4 | 57.4/0.2 |
≥ 2 visits/m (n = 41) | 46.6 | 62.4 | 53.9 | 45.2 | 56 | 54.8 | 53.3 | 58.3 | 50.7 |
Adm. period | |||||||||
< Half ttt period (n = 21) | 34.4/0.001* | 64.0/0.1 | 58.7/0.2 | 58.6/0.4 | 68.4/0.008* | 57.4/0.5 | 68.8/0.01* | 54.5/0.9 | 57.2/0.6 |
≥ Half ttt period (n = 89) | 57.9 | 51.9 | 53.0 | 53.0 | 51.0 | 53.3 | 51.0 | 53.8 | 53.3 |
Duration of treatment | |||||||||
< 3 m (n = 15) | 37.4/0.053 | 55.6/0.8 | 59.3/0.5 | 50.8/0.6 | 62.7/0.4 | 61.0/0.05 | 54.8/0.7 | 54.8/0.04* | 54.7/0.9 |
3–6 m (n = 18) | 56.5 | 57.8 | 54.2 | 49.2 | 54.9 | 38.9 | 51.5 | 71.3 | 55.7 |
≥ 6 months (n = 77) | 57.1 | 53.5 | 53.7 | 56.3 | 52.9 | 56.7 | 50.7 | 50.7 | 54.1 |
Cancer type | |||||||||
ALL (n = 63) | 58.3/0.2 | 54.8/0.7 | 55.2/0.8 | 56.7/0.6 | 56.0/0.8 | 60.1/0.06 | 58.9/0.1 | 55.7/0.9 | 58.3/0.2 |
Others (n = 47) | 51.7 | 56.4 | 55.8 | 53.9 | 54.7 | 49.3 | 50.8 | 55.1 | 51.6 |